Pharmaceuticals in Russia
Summary
Pharmaceuticals in Russia industry profile provides topline qualitative and quantitative summary information including: market share, market size value 201317, and forecast to 2022. The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.
Synopsis
Essential resource for topline data and analysis covering the Russia pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends, leading companies and macroeconomic information.
Key highlights
The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare.
The Russian pharmaceuticals market had total revenues of $23.4bn in 2017, representing a compound annual growth rate CAGR of 13.7% between 2013 and 2017.
A key driver of growth in market is that the country has a high smoking population and high alcohol consumption, which has led to cardiovascular diseases and cancer being prominent ailments.
In Russia, the pharmaceutical market is made up of two business segments: the government procurement and the commercial market. The market is largely controlled by the commercial segment, rather than government purchasing.
Scope
Save time carrying out entrylevel research by identifying the size, growth, and leading players in the pharmaceuticals market in Russia
Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the pharmaceuticals market in Russia
Leading company profiles reveal details of key pharmaceuticals market players' global operations and financial performance
Add weight to presentations and pitches by understanding the future growth prospects of the Russia pharmaceuticals market with five year forecasts
Reasons to buy
What was the size of the Russia pharmaceuticals market by value in 2017?
What will be the size of the Russia pharmaceuticals market in 2022?
What factors are affecting the strength of competition in the Russia pharmaceuticals market?
How has the market performed over the last five years?
Who are the top competitiors in Russia's pharmaceuticals market?